Cipher Pharmaceuticals Inc.
CPHR
CPHR was delisted on the 8th of December, 2016.
21 hedge funds and large institutions have $40.8M invested in Cipher Pharmaceuticals Inc. in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
11% more funds holding
Funds holding: 19 → 21 (+2)
1% more capital invested
Capital invested by funds: $40.2M → $40.8M (+$546K)
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$296K |
| 2 |
Morgan Stanley
New York
|
+$100K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$10.8K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.64K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$3.18K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAM
Taylor Asset Management
Toronto,
Ontario, Canada
|
-$1.12M |
| 2 |
IIM
Intact Investment Management
Montreal,
Quebec, Canada
|
-$873K |
| 3 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
-$463K |
| 4 |
MBI
Montrusco Bolton Investments
Montreal,
Quebec, Canada
|
-$234K |
| 5 |
AIC
AWM Investment Company
New York
|
-$221K |
CPHR Hedge Fund Activity: Q2 2016 in Review
21 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Cipher Pharmaceuticals Inc. (CPHR) for Q2 2016, worth a combined $40.8M — up 1.4% from $40.2M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CPHR positions and 1 closed out — a net gain of 2 holders — while 5 added to existing stakes and 9 trimmed.
The largest buyer was Connor, Clark & Lunn Investment Management (CC&L), opening a new position worth an estimated $296K. The largest seller was Taylor Asset Management, cutting an estimated $1.12M.
- 21 institutional investors held Cipher Pharmaceuticals Inc. (CPHR) as of Q2 2016, up from 19 in Q1 2016.
- Funds reported $40.8M of Cipher Pharmaceuticals Inc. stock for Q2 2016, up 1.4% quarter-over-quarter.
- 3 funds opened new Cipher Pharmaceuticals Inc. positions in Q2 2016 and 1 closed out, a net change of +2 holders.
- The largest Cipher Pharmaceuticals Inc. buyer in Q2 2016 was Connor, Clark & Lunn Investment Management (CC&L), an estimated $296K added.
- The largest Cipher Pharmaceuticals Inc. seller in Q2 2016 was Taylor Asset Management, an estimated $1.12M sold.
Based on aggregated 13F filings for Q2 2016.